Description
A Parkinson's disease model was created in lab mice. This paper refers to one phase of a study in which it will be determined whether a viral vector of glucocerebrosidase can be used as a clinical treatment for Parkinson's disease.

A Parkinson's disease model was created in lab mice. This paper refers to one phase of a study in which it will be determined whether a viral vector of glucocerebrosidase can be used as a clinical treatment for Parkinson's disease. The first part of this study involves creating a Parkinson's disease model in lab mice, which was talked about in the paper.
Reuse Permissions
  • 541.98 KB application/pdf

    Download restricted. Please sign in.
    Restrictions Statement

    Barrett Honors College theses and creative projects are restricted to ASU community members.

    Details

    Title
    • Comparing Neurodegeneration Levels in Mice Brains Using Different Disease Models
    Contributors
    Date Created
    2024-12
    Resource Type
  • Text
  • Machine-readable links